BIOMECORP is a biotechnology startup developing immune-active bioactive compounds derived from insects. Our platform enables the production of natural antimicrobial proteins, functional postbiotics and immune-modulatory ingredients that serve as sustainable alternatives to antibiotics in animal nutrition and functional food systems.
We combine molecular biology, immunology and insect biotechnology to create high-impact, scalable solutions for global challenges such as antimicrobial resistance, sustainable protein production and microbiome health.
Our technology platform covers:
Immune-trained insect protein fractions enriched in antimicrobial peptides
Functional feed additives for poultry, aquaculture and pet nutrition
Nutrigenomic and microbiome-supporting bioactive ingredients
Sustainable bioprocessing including optimized lyophilization and QC methods
We are actively seeking international SME partners for joint R&D, validation studies, scale-up activities and market-focused innovation projects within IraSME.
Advanced Biomanufacturing and Ecosystem Enablers
Scale-up and manufacturing of complex therapiesSustainable and green biomanufacturing
Next-generation therapeutics and modalities
Innovative antibiotics (new mechanisms of action, antimicrobial peptides, phage therapy, and alternatives to traditional antibiotics)